PCV74 COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE FOR THE PRIMARY PREVENTION OF VENOUSTHROMBOEMBOLISM IN PATIENTS UNDERGOINGTOTAL HIP ORTOTAL KNEE REPLACEMENT SURGERY
Abstract
Authors
S Wolowacz N Roskell F Maciver S Beard P Robinson J Plumb